VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.90 Cr | ₹-11 Cr | ₹-17 Cr | ₹-4.57 Cr | ₹-0.67 Cr |
What is the latest Cash Flow from Financing Activities ratio of VIMTA LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2024 | ₹-1.90 Cr |
| Mar2023 | ₹-11 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-4.57 Cr |
| Mar2020 | ₹-0.67 Cr |
How is Cash Flow from Financing Activities of VIMTA LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-1.90 Cr | Negative | |
| Mar2023 | ₹-11 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-4.57 Cr | Negative | |
| Mar2020 | ₹-0.67 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,071.0 Cr | 12% | 6.8% | -19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 12% |
6.8% |
-19.9% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses